Assenagon Asset Management S.A. Horizon Therapeutics Public LTD CO Transaction History

Assenagon Asset Management S.A.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$98.98 - $115.74 $118,083 - $138,077	-1,193 Reduced 16.32%	6,119 $707,000
Q2 2023 Jul 25, 2023	BUY	$96.34 - $112.38 $6,165 - $7,192	64 Added 0.88%	7,312 $752,000
Q1 2023 Apr 18, 2023	SELL	$107.32 - $113.5 $20.4 Million - $21.6 Million	-190,475 Reduced 96.33%	7,248 $791,000
Q4 2022 Jan 12, 2023	SELL	$62.39 - $113.8 $653,909 - $1.19 Million	-10,481 Reduced 5.03%	197,723 $22.5 Million
Q3 2022 Oct 27, 2022	SELL	$58.92 - $84.67 $3.26 Million - $4.68 Million	-55,309 Reduced 20.99%	208,204 $12.9 Million

Q2 2022 Jul 27, 2022	SELL	$79.4 - $116.36 $68.3 Million - $100 Million	-859,737 Reduced 76.54%	263,513 $21 Million
Q1 2022 Apr 25, 2022	BUY	$86.42 - $109.81 $87.6 Million - $111 Million	1,013,364 Added 922.2%	1,123,250 $118 Million
Q4 2021 Feb 01, 2022	SELL	$98.56 - $119.91 $31.9 Million - $38.8 Million	-323,475 Reduced 74.64%	109,886 $11.8 Million
Q3 2021 Oct 19, 2021	BUY	$91.91 - $110.37 $33.5 Million - $40.2 Million	364,321 Added 527.7%	433,361 $47.5 Million
Q2 2021 Jul 15, 2021	BUY	$86.24 - $95.92 $5.95 Million - $6.62 Million	69,040 New	69,040 $6.47 Million
Q3 2020 Oct 07, 2020	SELL	$55.23 - $79.93 $3.03 Million - $4.39 Million	-54,899 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$30.2 - $56.98 $1.66 Million - $3.13 Million	54,899 New	54,899 $3.05 Million
Q1 2020 Apr 17, 2020	SELL	$24.87 - $38.56 $1.64 Million - $2.54 Million	-65,830 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$25.43 - $36.67 $1.67 Million - $2.41 Million	65,830 New	65,830 $2.38 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.